These findings are comparable to the results of the phase 3 SUSTAIN clinical trials of semaglutide OW in which, across trials and ethnicity subgroups, weight reduced from baseline by 2.34.7 kg with a dose of 0.5 mg, and by 3.66.1 kg with 1 mg [34]
Contradictory findings from these studies could be likely explained, at least partly, by small sample sizes (and, consequently, by limited statistical power to detect associations) and also by narrow age ranges investigated (Der et al., 2012)
Heart Health Support: May help lower cholesterol and triglyceride levels, contributing to improved cardiovascular health
4 Week Walking Plan Are you ready to increase your step count
These weight loss injections can help patients reach their goal weight quickly and efficiently
Lab Work & Consultation: Complete labs and meet with your provider to review results